SITC Archive Library

Concurrent Session 212: Next Generation Checkpoint Blockade: Mechanisms of Action 

11-23-2022 13:41

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 212: Next Generation Checkpoint Blockade: Mechanisms of Action" during the 37th Annual Meeting & Pre-Conference Programs on November 11, 2022. Available here are the presentation slides and video from the session, as permitted by presenters.

SESSION CO-CHAIRS

  • Ana Carrizosa Anderson, PhD – Harvard Medical School
  • Ira Mellman, PhD – Genentech

      37TH ANNUAL MEETING ORGANIZERS

      • Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
      • Sacha Gnjatic, PhD – Icahn School of Medicine at Mount Sinai
      • Jillian Hunt, AOCNP – Cincinnati Cancer Advisors
      • Andrea Schietinger, PhD – Memorial Sloan Kettering Cancer Center
      • Ryan J. Sullivan, MD – Massachusetts General Hospital

      ANNUAL PROGRAM COMMITTEE

      • Chair: Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
      • Niroshana Anandasabapathy, MD, PhD – Weill Cornell Medicine
      • Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center
      • Lorenzo Falchi, MD – Memorial Sloan Kettering Cancer Center
      • Michelle Rohlfs, APRN, FANP-BC, AOCNP – The University of Texas MD Anderson Cancer Center

      TARGET AUDIENCE

      The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

      To view the entire program schedule (including presenter permission to post) please click here.

      Statistics
      0 Favorited
      49 Views
      2 Files
      0 Shares
      17 Downloads
      Attachment(s)
      pptx file
      "(504) PVRIG, a novel T cell checkpoint, is preferentiall...   18.82 MB   1 version
      Uploaded - 12-22-2022
      SITC 2022 Annual Meeting: Friday, November 11; Eran Ophir, PhD

      Related Entries and Links

      No Related Resource entered.